Cellebrite director reports 17,804 Ordinary Shares

Cellebrite DI Ltd. director Michael D. Capellas reported his initial holdings of 17,804 Ordinary Shares.

Rhea-AI Filing Summary

Cellebrite DI Ltd. director Michael D. Capellas reported his initial holdings of 17,804 Ordinary Shares. This includes 9,494 Ordinary Shares represented by restricted share units granted on January 1, 2026, which are scheduled to vest on January 1, 2027, each RSU delivering one Ordinary Share upon settlement.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider CAPELLAS MICHAEL D

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	--	--	--

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 ("Ordinary Shares") — 17,804 shares (Direct)

Footnotes (1)

1. F1. Includes 9,494 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on January 1, 2026 and vest on January 1, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Michael D. Capellas report in his Cellebrite (CLBT) Form 3 filing?

Michael D. Capellas reports ownership of 17,804 Ordinary Shares of Cellebrite DI Ltd. This total includes both currently held shares and restricted share units that may convert into shares upon future vesting and settlement.

How many Cellebrite (CLBT) RSUs does Michael D. Capellas hold?

Michael D. Capellas holds 9,494 restricted share units (RSUs) in Cellebrite DI Ltd. Each RSU represents a contingent right to receive one Ordinary Share when it settles, subject to the specified vesting schedule.

When do Michael D. Capellas’s Cellebrite (CLBT) RSUs vest?

The 9,494 RSUs granted to Michael D. Capellas on January 1, 2026 are scheduled to vest on January 1, 2027. After vesting and settlement, each RSU is expected to deliver one Ordinary Share.

Are Michael D. Capellas’s Cellebrite (CLBT) holdings direct or indirect?

The Form 3 indicates that Michael D. Capellas’s 17,804 Ordinary Shares are held with direct ownership. The filing does not attribute these shares to any separate trust, partnership, or other indirect holding entity.

Does this Cellebrite (CLBT) Form 3 show any insider buying or selling?

This Form 3 records initial beneficial ownership of Cellebrite shares by Michael D. Capellas. It does not report any specific purchase or sale transactions, focusing instead on the total direct holdings and related restricted share units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 08:18 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CAPELLAS MICHAEL D

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	17,804(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 9,494 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on January 1, 2026 and vest on January 1, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

	/s/ Michael Capellas	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)